Home / Market News / $BDX

$BDX news and market catalysts

The 21 most recent market catalysts affecting $BDX, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.

21 catalysts 4 high impact 16 bullish 1 bearish Medical Devices
Nov 18, 2026 Corporate Catalyst Bullish Impact 55
Becton, Dickinson and Company Announces Collaboration with AHA and West Health Institute
Becton, Dickinson and Company (BD) has announced a collaboration with the American Hospital Association (AHA) and the West Health Institute to facilitate the adoption of advanced m…
Nov 10, 2026 Corporate Catalyst Neutral Impact 55
BD Announces Investor Day for December 10, 2026
BD (Becton, Dickinson and Company) has announced an Investor Day scheduled for December 10, 2026. This event is significant as it provides a platform for the company's leadership, …
Nov 6, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Adjusts Price Target on Becton, Dickinson and Company
Piper Sandler announced an upward revision of its price target for Becton, Dickinson and Company (BDX) from $175 to $200. This change indicates increased confidence from the analys…
Nov 6, 2026 Corporate Catalyst Bullish Impact 55
RBC Raises Price Target on Becton, Dickinson and Company
RBC has raised its price target for Becton, Dickinson and Company (BDX) to $225 from $190. This adjustment signals RBC's increased confidence in the company's future performance or…
Nov 6, 2026 Corporate Catalyst Bullish Impact 55
Piper Sandler Adjusts Price Target on Becton, Dickinson and Company
Piper Sandler, a prominent investment bank, has raised its price target for Becton, Dickinson and Company (BDX) from $175 to $200. This upward revision indicates that the analyst f…
Nov 6, 2026 Corporate Catalyst Bullish Impact 60
Wells Fargo Upgrades Becton, Dickinson and Company to Overweight
Wells Fargo upgraded Becton, Dickinson and Company (BDX) to Overweight from Equalweight on November 6, 2026. This upgrade indicates that Wells Fargo analysts believe BDX's stock is…
Nov 5, 2026 Corporate Catalyst Bullish Impact 95
Becton, Dickinson and Company Reports Fiscal 2026 Fourth Quarter and Full Year Financial Results
Becton, Dickinson and Company (BD) announced its fiscal 2026 fourth-quarter and full-year financial results, reporting Q4 revenue of $5.3 billion and adjusted EPS of $4.15, along w…
Nov 5, 2026 Corporate Catalyst Bullish Impact 55
BD Declares Quarterly Dividend and Authorizes New Share Repurchase Program
BD declared a quarterly dividend increase of 1.0% to $1.06 per share, extending its streak of dividend increases to 55 years. This consistent dividend growth signals financial stab…
Oct 27, 2026 Corporate Catalyst Neutral Impact 65
Budimex S.A. Publishes Financial Results
Budimex S.A. has filed its financial results for the period ending in 2026 through the ESPI system. This is a standard regulatory disclosure that provides stakeholders with a compr…
Oct 23, 2026 Corporate Catalyst Bullish Impact 65
Budimex Selected for Tramway and Road Infrastructure Project in Katowice
Budimex SA has officially secured a contract for a substantial infrastructure project in Katowice, involving road network expansion and tram line construction. This is a positive d…
Oct 7, 2026 Corporate Catalyst Neutral Impact 55
Barclays Initiates Coverage On Becton Dickinson with Underweight Rating, Announces Price Target of $165
Barclays analyst Christopher Pasquale has initiated coverage on Becton Dickinson (BDX) with an 'Underweight' rating and a price target of $165. This is a new analyst opinion enteri…
Oct 6, 2026 Corporate Catalyst Bullish Impact 85
Becton Dickinson Commits Massive $19 Billion To Expand Domestic Medical Manufacturing
Becton Dickinson (BDX) is making a substantial $19 billion commitment, with $3 billion directly allocated to expanding its U.S. manufacturing facilities. This move is a direct resp…
Oct 6, 2026 Corporate Catalyst Bullish Impact 75
Becton Dickinson To Invest $3B U.S. Domestic Manufacturing To Expand Output By 5B Medical Consumables Per Year; Will Invest $19B In The U.S. Over Several Years
Becton Dickinson (BDX) is committing $19 billion to the U.S. over several years, with $3 billion directly allocated to expanding domestic manufacturing. This substantial investment…
Aug 19, 2026 Corporate Catalyst Bearish Impact 55
What's Going On With Becton Dickinson Stock Wednesday?
The FDA announced that Becton Dickinson (BDX) is recalling specific sodium chloride ampules found in its convenience kits due to potential contamination risks. While this is a prod…
Aug 12, 2026 Corporate Catalyst Bullish Impact 55
Becton, Dickinson And Co. Completes Enrollment In PREVENT Clinical Trial Evaluating Phasix Mesh For Prevention Of Incisional Hernias
BD (Becton, Dickinson and Company) has completed patient enrollment in its PREVENT clinical trial, which is evaluating Phasix Mesh for the prevention of incisional hernias. This is…
Aug 7, 2026 Corporate Catalyst Bullish Impact 55
Citigroup Maintains Buy on Becton Dickinson, Raises Price Target to $204
Citigroup analyst Joanna Wiensch maintained a 'Buy' rating on Becton Dickinson and raised the price target from $198 to $204. This action signals continued confidence in the compan…
Aug 7, 2026 Corporate Catalyst Bullish Impact 55
Wells Fargo Maintains Equal-Weight on Becton Dickinson, Raises Price Target to $170
Wells Fargo analyst Lawrence Biegelsen reiterated an 'Equal-Weight' rating on Becton Dickinson (BDX) but raised the price target from $161 to $170. This action signals a modest inc…
Aug 6, 2026 Corporate Catalyst Bullish Impact 85
Beckton, Dickinson shares are trading higher after the company reported better-than-expected Q3 financial results and raised its FY26 adjusted EPS guidance above estimates.
This headline is a significant positive catalyst for Beckton, Dickinson (BDX) due to better-than-expected earnings and an upward revision of future guidance. This indicates strong …
Aug 6, 2026 Corporate Catalyst Bullish Impact 85
Becton Dickinson Signals Strong Growth Momentum By Raising Profit Outlook
Becton Dickinson (BDX) significantly outperformed analyst expectations for both Q3 adjusted earnings and sales, demonstrating robust growth across its diverse medical technology se…
Aug 5, 2026 Corporate Catalyst Bullish Impact 55
TD Cowen Maintains Hold on Becton Dickinson, Raises Price Target to $182
TD Cowen analyst Joshua Jennings maintained a 'Hold' rating on Becton Dickinson (BDX) but raised the price target from $163 to $182. This action reflects a slightly improved outloo…
Jul 28, 2026 Corporate Catalyst Neutral Impact 55
UBS Initiates Coverage On Becton Dickinson with Buy Rating, Announces Price Target of $190
UBS analyst Patrick Wood initiated coverage on Becton Dickinson (BDX) with a 'Buy' rating and set a price target of $190. This event signals a new institutional endorsement of the …
Join the waitlist for full signal validation →

Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.